FDA Orange Book
Generic for Iyuzeh
Iyuzeh contains latanoprost. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Iyuzeh is latanoprost. 7 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AT.
Run it in Rivvi
Map Iyuzeh and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Iyuzeh products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution/drops, ophthalmic | 0.005% | Marketed (Rx) | None | 7 | AT |
NDA 216472, held by THEA PHARMA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic latanoprost
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| BAUSCH AND LOMB INC | 201006 | AT (A-rated, therapeutically equivalent) | March 22, 2011 | 0.005% |
| J MOLNER HOLDINGS INC | 200925 | AT (A-rated, therapeutically equivalent) | March 22, 2011 | 0.005% |
| SANDOZ INC | 091449 | AT (A-rated, therapeutically equivalent) | March 22, 2011 | 0.005% |
| SOMERSET THERAPEUTICS LLC | 201786 | AT (A-rated, therapeutically equivalent) | March 22, 2011 | 0.005% |
| FDC LTD | 202442 | AT (A-rated, therapeutically equivalent) | April 22, 2016 | 0.005% |
| GLAND PHARMA LTD | 218257 | AT (A-rated, therapeutically equivalent) | November 26, 2024 | 0.005% |
| MICRO LABS LTD | 219306 | AT (A-rated, therapeutically equivalent) | April 14, 2025 | 0.005% |
Iyuzeh patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8637054 | July 8, 2031 | Drug product | U-446 | 216472 |
Iyuzeh NDC codes
Questions
Is there a generic for Iyuzeh?
Yes. The generic name for Iyuzeh is latanoprost. 7 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AT.
What is the generic name for Iyuzeh?
The active ingredient in Iyuzeh is latanoprost, per the FDA Orange Book.
When does the Iyuzeh patent expire?
The last patent listed for Iyuzeh in the Orange Book expires July 8, 2031. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.